191 related articles for article (PubMed ID: 18194138)
1. Oral mucosa lesions in hypereosinophilic syndrome--an update.
Ionescu MA; Murata H; Janin A
Oral Dis; 2008 Mar; 14(2):115-22. PubMed ID: 18194138
[TBL] [Abstract][Full Text] [Related]
2. Hypereosinophilic syndrome and proliferative diseases.
Ionescu MA; Wang L; Janin A
Acta Dermatovenerol Croat; 2009; 17(4):323-30. PubMed ID: 20021987
[TBL] [Abstract][Full Text] [Related]
3. Hypereosinophilic syndromes.
Roufosse FE; Goldman M; Cogan E
Orphanet J Rare Dis; 2007 Sep; 2():37. PubMed ID: 17848188
[TBL] [Abstract][Full Text] [Related]
4. [The idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia].
Chrobák L; Voglová J
Vnitr Lek; 2005 Dec; 51(12):1385-93. PubMed ID: 16430106
[TBL] [Abstract][Full Text] [Related]
5. Hypereosinophilic syndrome: case presentation and update.
Leiferman KM; Gleich GJ
J Allergy Clin Immunol; 2004 Jan; 113(1):50-8. PubMed ID: 14713907
[TBL] [Abstract][Full Text] [Related]
6. [Isolated mucosal ulcers disclosing idiopathic hypereosinophilic syndrome].
Billon C; Gautier C; Villaret E; Ducos MH; Martin JC; Geniaux M
Ann Dermatol Venereol; 1997; 124(3):248-50. PubMed ID: 9686058
[TBL] [Abstract][Full Text] [Related]
7. Hypereosinophilic syndrome: an update.
Wilkins HJ; Crane MM; Copeland K; Williams WV
Am J Hematol; 2005 Oct; 80(2):148-57. PubMed ID: 16184589
[TBL] [Abstract][Full Text] [Related]
8. Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy.
Gotlib J; Cross NC; Gilliland DG
Best Pract Res Clin Haematol; 2006; 19(3):535-69. PubMed ID: 16781488
[TBL] [Abstract][Full Text] [Related]
9. [Idiopathic hypereosinophilic syndrome: toward a new molecular-targeted therapy and a new cytomorphological and molecular definition].
Moles MP; Landry J; Roche-Lestienne C; Godon A; Schmidt-Tanguy A; Gardembas M; Le Clech C; Verret JL; Zandecki M; Blanchet O
Ann Biol Clin (Paris); 2005; 63(3):317-22. PubMed ID: 15951264
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytic variant hypereosinophilic syndromes.
Roufosse F; Cogan E; Goldman M
Immunol Allergy Clin North Am; 2007 Aug; 27(3):389-413. PubMed ID: 17868856
[TBL] [Abstract][Full Text] [Related]
11. The hypereosinophilic syndromes: still more heterogeneity.
Gleich GJ; Leiferman KM
Curr Opin Immunol; 2005 Dec; 17(6):679-84. PubMed ID: 16214314
[TBL] [Abstract][Full Text] [Related]
12. Imatinib: new indication. New indications, but not robust evidence.
Prescrire Int; 2008 Jun; 17(95):91-4. PubMed ID: 18623899
[TBL] [Abstract][Full Text] [Related]
13. Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinib.
Hofmann SC; Technau K; Müller AM; Lübbert M; Bruckner-Tuderman L
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S68-72. PubMed ID: 17097375
[TBL] [Abstract][Full Text] [Related]
14. Mucosal ulcerations revealing primitive hypereosinophilic syndrome.
Barouky R; Bencharif L; Badet F; Salles G; Vital Durand D; Rousset H
Eur J Dermatol; 2003; 13(2):207-8. PubMed ID: 12695143
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic hypereosinophilic syndrome: a case evolving in B-lymphoblastic lymphoma.
Rapanotti MC; Caruso R; Bernardini S; Coletti V; Lo-Coco F; De Rossi G
Leuk Res; 2005 Aug; 29(8):975-9. PubMed ID: 15978951
[TBL] [Abstract][Full Text] [Related]
16. Hypereosinophilic syndrome: diagnosis and treatment.
Peros-Golubicić T; Smojver-Jezek S
Curr Opin Pulm Med; 2007 Sep; 13(5):422-7. PubMed ID: 17940488
[TBL] [Abstract][Full Text] [Related]
17. Hypereosinophilic syndrome - lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestations.
d'Elbée JM; Parrens M; Mercié P; Longy Boursier M; Dieval C; de Mascarel A; Duffau P; Dubus P; Fricain JC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):e185-90. PubMed ID: 23669204
[TBL] [Abstract][Full Text] [Related]
18. Unique presentation of hypereosinophilic syndrome: recurrent mitral prosthetic valve thrombosis without endomyocardial disease.
Jánoskuti L; Förhécz Z; Lengyel M
J Heart Valve Dis; 2006 Sep; 15(5):726-9. PubMed ID: 17044383
[TBL] [Abstract][Full Text] [Related]
19. Recent breakthroughs in the understanding and management of chronic eosinophilic leukemia.
Lierman E; Cools J
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1295-304. PubMed ID: 19761433
[TBL] [Abstract][Full Text] [Related]
20. 6q- is an early and persistent chromosomal aberration in CD3-CD4+ T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome.
Ravoet M; Sibille C; Roufosse F; Duvillier H; Sotiriou C; Schandené L; Martiat P; Goldman M; Willard-Gallo KE
Haematologica; 2005 Jun; 90(6):753-65. PubMed ID: 15951288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
